ANI Pharmaceuticals | ANIP - الأصول





الأصول تغيير تاريخ
AbbVie USD 136.46B 2.5B 2026-03
ANI Pharmaceuticals USD 1.42B 18.41M 2026-03
Aurora Cannabis CAD 601.09M 174.2M 2026-03
Canopy Growth CAD 1.12B 12.54M 2026-03
Eli Lilly USD 116.58B 4.1B 2026-03
Emergent BioSolutions USD 1.82B 69.9M 2023-12
Heron Therapeutics USD 246.22M 9.66M 2026-03
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Novartis USD 118.53B 7.58B 2026-03
Omeros USD 200.57M 34.59M 2025-06
Perrigo USD 7.98B 551.9M 2026-03
Sun Pharmaceuticals INR 1.09T 50.79B 2026-03
Teva Pharmaceutical Industries USD 40.04B 708M 2026-03